Nssofttissuedisorders
•Download as PPTX, PDF•
0 likes•786 views
This document discusses different types of grips for lifting objects. It compares normal grips, cam grips that use friction, and pincer grips that use the tips of the fingers and thumb. The document considers the questions of grip types and their effectiveness for lifting.
Report
Share
Report
Share
Recommended
Anca talk
This document discusses the clinical features and treatment of ANCA-associated vasculitis. It begins by defining vasculitis and describing the different types. It then focuses on ANCA-associated vasculitis, describing the characteristics of Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Eosinophilic Granulomatosis with Polyangiitis (EGPA). For treatment, it recommends cyclophosphamide or rituximab combined with steroids for inducing remission of GPA and MPA. Azathioprine or methotrexate are used to maintain remission. EGPA is primarily treated with steroids, with cyclophosphamide added for more
Connective Tissue Diseases
This document provides an overview of connective tissue diseases, including systemic lupus erythematosus (SLE) and systemic sclerosis. It discusses diagnostic criteria and biomarkers for SLE such as anti-nuclear antibodies (ANA) and disease-specific autoantibodies. Treatment options for SLE and lupus nephritis are reviewed, including hydroxychloroquine, belimumab, and the Aspreva Lupus Management Study comparing mycophenolate mofetil to intravenous cyclophosphamide. The roles of BAFF/APRIL in SLE pathogenesis and as therapeutic targets are also summarized. Finally, the document distinguishes between diffuse and limited subtypes of systemic sclerosis.
Lupus nephritis
1. Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organ systems.
2. SLE is characterized by the production of autoantibodies directed against cell nuclei.
3. Treatment of lupus nephritis involves induction therapy with corticosteroids and cytotoxic agents to control disease activity, followed by long-term maintenance treatment to prevent flares and preserve renal function.
Pathophysiology of lupus nephritis
Systemic lupus erythematosus (SLE) is an autoimmune disease where organs and cells are damaged by autoantibodies and immune complexes. It predominantly affects women aged 15-45 and can involve any organ. Renal involvement, known as lupus nephritis, ranges from mild mesangial proliferation to severe necrotizing glomerulonephritis. A renal biopsy is needed to classify lupus nephritis based on immune deposits and patterns of injury, which guides treatment and prognosis.
April journal watch
This document provides a summary of articles across various medical specialties discussed in the April 2015 edition of the UTSW Journal Watch. In the Hepatology section, an article is summarized that finds corticosteroids may be safely used in patients with severe alcoholic hepatitis who present with an upper GI bleed after bleeding is controlled. In Pulmonary/Critical Care, a summary is provided of a trial finding no difference in mortality between early goal-directed therapy and usual care for treating septic shock. The study suggests protocols for goals of care are less important than early antibiotics and fluids. In Nephrology, a meta-analysis summary indicates preoperative use of renin-angiotensin system inhibitors may be linked to
Ct dip
The CT chest scan showed mosaic attenuation with air-trapping as well as an increase in size of a non-calcified lingular nodule and other scattered nodules.
B agusala womens health final
This document summarizes guidelines for screening and treatment related to gynecologic health in menopausal women. It discusses recommendations and risks for cervical and breast cancer screening, as well as guidelines for and risks of hormone replacement therapy. It also reports on non-hormonal options for treating post-menopausal symptoms like hot flashes. The document provides this information through a series of clinical vignettes and recommendations based on evidence from sources like the USPSTF.
Depression slides
This document provides guidance on identifying and managing clinically significant depression for internists. It outlines how to take a thorough history to assess for depression, safety risks, substance use, bipolarity and psychosis. Common mimics of depression like delirium, substance withdrawal and medical condition-related depression are reviewed. First-line antidepressant medications are SSRIs, SNRIs, bupropion and mirtazapine. The document describes strategies for patients who do not improve on initial treatment, such as switching or augmenting medications. Non-pharmacological approaches like exercise and social support are also encouraged.
Recommended
Anca talk
This document discusses the clinical features and treatment of ANCA-associated vasculitis. It begins by defining vasculitis and describing the different types. It then focuses on ANCA-associated vasculitis, describing the characteristics of Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Eosinophilic Granulomatosis with Polyangiitis (EGPA). For treatment, it recommends cyclophosphamide or rituximab combined with steroids for inducing remission of GPA and MPA. Azathioprine or methotrexate are used to maintain remission. EGPA is primarily treated with steroids, with cyclophosphamide added for more
Connective Tissue Diseases
This document provides an overview of connective tissue diseases, including systemic lupus erythematosus (SLE) and systemic sclerosis. It discusses diagnostic criteria and biomarkers for SLE such as anti-nuclear antibodies (ANA) and disease-specific autoantibodies. Treatment options for SLE and lupus nephritis are reviewed, including hydroxychloroquine, belimumab, and the Aspreva Lupus Management Study comparing mycophenolate mofetil to intravenous cyclophosphamide. The roles of BAFF/APRIL in SLE pathogenesis and as therapeutic targets are also summarized. Finally, the document distinguishes between diffuse and limited subtypes of systemic sclerosis.
Lupus nephritis
1. Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organ systems.
2. SLE is characterized by the production of autoantibodies directed against cell nuclei.
3. Treatment of lupus nephritis involves induction therapy with corticosteroids and cytotoxic agents to control disease activity, followed by long-term maintenance treatment to prevent flares and preserve renal function.
Pathophysiology of lupus nephritis
Systemic lupus erythematosus (SLE) is an autoimmune disease where organs and cells are damaged by autoantibodies and immune complexes. It predominantly affects women aged 15-45 and can involve any organ. Renal involvement, known as lupus nephritis, ranges from mild mesangial proliferation to severe necrotizing glomerulonephritis. A renal biopsy is needed to classify lupus nephritis based on immune deposits and patterns of injury, which guides treatment and prognosis.
April journal watch
This document provides a summary of articles across various medical specialties discussed in the April 2015 edition of the UTSW Journal Watch. In the Hepatology section, an article is summarized that finds corticosteroids may be safely used in patients with severe alcoholic hepatitis who present with an upper GI bleed after bleeding is controlled. In Pulmonary/Critical Care, a summary is provided of a trial finding no difference in mortality between early goal-directed therapy and usual care for treating septic shock. The study suggests protocols for goals of care are less important than early antibiotics and fluids. In Nephrology, a meta-analysis summary indicates preoperative use of renin-angiotensin system inhibitors may be linked to
Ct dip
The CT chest scan showed mosaic attenuation with air-trapping as well as an increase in size of a non-calcified lingular nodule and other scattered nodules.
B agusala womens health final
This document summarizes guidelines for screening and treatment related to gynecologic health in menopausal women. It discusses recommendations and risks for cervical and breast cancer screening, as well as guidelines for and risks of hormone replacement therapy. It also reports on non-hormonal options for treating post-menopausal symptoms like hot flashes. The document provides this information through a series of clinical vignettes and recommendations based on evidence from sources like the USPSTF.
Depression slides
This document provides guidance on identifying and managing clinically significant depression for internists. It outlines how to take a thorough history to assess for depression, safety risks, substance use, bipolarity and psychosis. Common mimics of depression like delirium, substance withdrawal and medical condition-related depression are reviewed. First-line antidepressant medications are SSRIs, SNRIs, bupropion and mirtazapine. The document describes strategies for patients who do not improve on initial treatment, such as switching or augmenting medications. Non-pharmacological approaches like exercise and social support are also encouraged.
Back pain lecture april 22 2015
This document discusses the evaluation and treatment of low back pain. It notes that low back pain is very common, affecting 90% of people and costing $40 billion annually. For acute low back pain, the short answer is to leave patients alone and for chronic pain, recommend back classes and functional rehabilitation. Red flags to evaluate for include cancer, infection, or neurological deficits. The goal is to distinguish the 95% with simple back pain from the 5% with serious underlying issues. Conservative treatment is usually sufficient, with opioids not recommended for chronic pain due to lack of evidence of long-term benefit and risk of harm.
Back pain lecture april 22 2015
This document discusses the evaluation and treatment of low back pain. It notes that low back pain is very common, affecting 90% of people and costing $40 billion annually. For acute low back pain, the short answer is to leave patients alone and for chronic pain, recommend back classes and functional rehabilitation. Red flags to evaluate for include cancer, infection, or neurological deficits. The goal is to distinguish the 95% with simple back pain from the 5% with a serious underlying problem. Conservative treatment including education, exercise, and over-the-counter medications is usually sufficient. Opioids are not recommended for chronic back pain due to lack of evidence of long-term benefit and risk of harm.
Atypical hus
This document summarizes a presentation on atypical hemolytic uremic syndrome (aHUS). The key points are:
1) Atypical HUS is caused by dysregulation of the alternative complement pathway leading to thrombotic microangiopathy. There is often an underlying genetic predisposition that is triggered by stressors like pregnancy.
2) Treatment with plasma therapy and transplantation previously had limited success due to recurrent disease.
3) The monoclonal antibody eculizumab, a C5 inhibitor, is highly effective at treating and preventing recurrence of aHUS. However, the high cost of the medication presents barriers to treatment.
Preop pulmonary evaluation 4 16-15
Mr. Lung is a 78-year-old man scheduled for a 4-hour L3-5 laminectomy and fusion who has severe COPD, diabetes, hypertension, and a 40 pack-year smoking history. He takes medications for his COPD and other conditions and is functionally independent but dyspneic with exertion. Preoperative evaluation shows he is at increased risk for postoperative pulmonary complications according to several risk prediction models. Recommendations are made for postoperative lung expansion techniques and monitoring to help mitigate his risks.
Bowen predm cme.4.9.15
Based on the evidence presented in the document, the appropriate recommendation for Mrs. K would be a lifestyle intervention with a goal of 7% weight loss (Option B). The DPP trial demonstrated that lifestyle intervention, aimed at 7% weight loss through diet and exercise, reduced the risk of developing diabetes by 58% over 3 years compared to placebo. This lifestyle intervention was more effective than metformin alone in preventing diabetes.
Bowen predm cme.4.9.15
1. The Diabetes Prevention Program (DPP) found that an intensive lifestyle intervention aimed at 7% weight loss was more effective than metformin or placebo at preventing diabetes in patients with prediabetes over 3 years, with a 58% reduction in relative risk.
2. For Mrs. K, an intensive lifestyle intervention targeting at least 7% weight loss would be the recommended first-line evidence-based approach based on the DPP findings.
3. After 1 year of lifestyle changes, Mrs. K had achieved 6% weight loss and normal fasting glucose and A1C levels, indicating response to treatment. However, 12 months later with 10 pounds regained, her glucose levels have
Cap2015
Community-acquired pneumonia (CAP) is a leading cause of death and hospitalization in the United States. Guidelines recommend using severity of illness scores like CURB-65 to determine appropriate site of care and empiric antibiotic therapy including β-lactams with macrolides or fluoroquinolones. Studies show guideline-concordant therapy improves outcomes. Procalcitonin levels may help determine duration of antibiotics, with lower levels associated with shorter treatment. Overall, clinicians should aim for 5-7 days of effective antibiotics guided by clinical and procalcitonin findings to optimize CAP treatment.
Resident update talk
This document summarizes information on altitude physiology and acute illnesses that can occur at high altitude. It discusses how oxygen levels decrease with increasing altitude, leading to tissue hypoxia. It describes the body's acclimatization process through various pulmonary, cardiovascular, cerebrovascular, and hematologic adaptations. The most common high altitude illnesses are acute mountain sickness, high altitude cerebral edema, and high altitude pulmonary edema. The document provides details on risk factors, symptoms, treatments, and prevention strategies for each of these illnesses. It emphasizes the importance of gradual ascent and allowing time for acclimatization to reduce risks.
Complications of cirrhosis review
This document discusses complications that can arise in patients with cirrhosis, including portal hypertension, ascites, hepatic encephalopathy, and hepatorenal syndrome. It provides details on the pathophysiology, clinical presentation, diagnosis, and treatment of these complications. Specifically, it focuses on portal hypertension and the development of varices, describing the risks of variceal bleeding and approaches to prevention and management. It also covers ascites extensively, explaining how and why it develops in cirrhosis and its treatment with diuretics and sodium restriction.
Bayat update talk
This document provides an overview of various food intoxications, covering bacteria such as Staphylococcus aureus, Bacillus cereus, Clostridium perfringens, and toxins including ciguatera, scombroid, tetrodotoxin, and domoic acid from contaminated shellfish. It describes the organisms and toxins involved, foods commonly associated with poisoning, symptoms, mechanisms of toxicity, and treatments for each type of food intoxication.
Peptic ulcer may 2015
This document summarizes key information about peptic ulcer disease and Helicobacter pylori (H. pylori). It discusses how H. pylori eradication benefits active gastric ulcer, past duodenal ulcer, and gastric MALT lymphoma. Proton pump inhibitors, sucralfate, and misoprostol are effective in decreasing NSAID-induced ulcers. H. pylori infection is associated with gastric adenocarcinoma through a sequence of events. Triple therapy is the preferred first line treatment for H. pylori, while quadruple therapy is used for retreatment. Risk of NSAID-induced ulcers increases with corticosteroid use, anticoagulant use,
March 192015talkforresidents final03232015 (1)
This document provides an update on viral hepatitis and discusses two case studies. It begins by describing a 71-year-old male presenting with jaundice who is diagnosed with acute hepatitis A infection based on a reactive HAV IgM test. It then reviews hepatitis A virus and the diagnosis and management of acute hepatitis A. The second case discusses a 26-year-old male diagnosed with chronic hepatitis B infection based on positive HBsAg, anti-HBc IgM, and HBV DNA tests. The document concludes by discussing chronic hepatitis B infection and approved treatments.
Final ipf journal club presentation
This summary reviews a journal club discussion on two phase 3 clinical trials evaluating the efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF). The trials found that nintedanib significantly reduced the rate of decline in forced vital capacity (FVC) over 52 weeks compared to placebo. There was no consistent effect on time to first acute exacerbation or change in symptoms. Common side effects included diarrhea. While the study design was valid, questions remain regarding the clinical significance of the outcomes and relevance of factors like smoking status.
Res update final
This document discusses the increasing use of therapeutic monoclonal antibodies in internal medicine. It provides examples of monoclonal antibodies used in various specialties like hematology/oncology, rheumatology, gastroenterology, and cardiology. The document outlines the historical development of monoclonal antibody technology from the 1890s to modern advances in recombinant DNA and transgenic mice that have allowed for humanized monoclonal antibodies. It notes both the benefits monoclonal antibodies have provided but also the issues of diminishing response, high costs, and sometimes unanticipated safety risks. The document concludes by predicting more monoclonal antibody approvals and emphasizes the need for rigorous evaluation of safety, efficacy and cost-effectiveness as with other medical therapies.
Resident update talk jtw online
This document summarizes various approaches for managing type 1 diabetes, including the bionic pancreas, islet transplantation, and stem cell therapy. It notes that the bionic pancreas can help improve glucose control but has limitations like being invasive and not physiological. Islet transplantation via the Edmonton protocol can cure diabetes, but challenges remain in expanding the donor supply and improving techniques. Stem cell therapy shows promise if stem cells can be encapsulated to both differentiate into insulin-producing cells and avoid immune rejection. Overall, a cure exists on the horizon, but further progress is still needed to overcome immune issues and increase donor availability.
Hfpef
HFPEF is defined as clinical signs of congestive heart failure with a preserved left ventricular ejection fraction over 50%. It accounts for about half of all heart failure cases and is associated with significant mortality. The pathophysiology involves abnormal ventricular stiffness from an upward and leftward shift in the end diastolic pressure-volume relationship. This results in poor exercise tolerance and fatigue. While the exact causes are unclear, comorbidities like hypertension, diabetes and obesity likely play a key role. No treatments shown to improve outcomes for heart failure with reduced ejection fraction have been effective for HFPEF.
IBD
This document discusses the diagnosis and management of ulcerative colitis and Crohn's disease. It defines the diseases, describes their classification systems and severity indices. It covers epidemiology, pathogenesis, diagnostic testing and differential diagnoses. Treatment strategies are outlined for induction and maintenance of remission for mild to severe ulcerative colitis. Management of Crohn's disease is discussed including medications such as aminosalicylates, corticosteroids, immunomodulators, biologics and their monitoring. Surgical options are also summarized.
Noon conference Pancreatic disorders
This document discusses pancreatic function and pathophysiology of pancreatitis. It covers the exocrine and endocrine functions of the pancreas. For acute pancreatitis, it details etiologies including gallstones, alcohol, hypertriglyceridemia, drugs, infections and others. It discusses clinical presentation, severity scoring, management including nutrition and imaging. For chronic pancreatitis, it covers presentation, complications and treatments.
Resident updatetalk
This document discusses cardiac amyloidosis, a rare disorder where abnormal proteins deposit in the heart muscle, causing restrictive cardiomyopathy. It begins by describing the patient case of a man presenting with heart failure symptoms and an echocardiogram showing thickened heart walls. The document then provides background on amyloidosis, including definitions, types, pathogenesis, typical symptoms, diagnostic methods like biopsy, and treatments like chemotherapy, stem cell transplant, and newer therapies.
Resident updatetalk
This document discusses cardiac amyloidosis, a rare disease where abnormal proteins deposit in the heart muscle, causing restrictive cardiomyopathy. It begins by describing the case of a 53-year-old man presenting with chest discomfort and edema. The document then provides background on amyloidosis, including its historical context and pathophysiology. It describes the typical presentation of cardiac amyloidosis and diagnostic methods. The document concludes by reviewing current treatments and their outcomes, such as stem cell transplantation which can achieve long-term remission in some patients.
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
More Related Content
More from katejohnpunag
Back pain lecture april 22 2015
This document discusses the evaluation and treatment of low back pain. It notes that low back pain is very common, affecting 90% of people and costing $40 billion annually. For acute low back pain, the short answer is to leave patients alone and for chronic pain, recommend back classes and functional rehabilitation. Red flags to evaluate for include cancer, infection, or neurological deficits. The goal is to distinguish the 95% with simple back pain from the 5% with serious underlying issues. Conservative treatment is usually sufficient, with opioids not recommended for chronic pain due to lack of evidence of long-term benefit and risk of harm.
Back pain lecture april 22 2015
This document discusses the evaluation and treatment of low back pain. It notes that low back pain is very common, affecting 90% of people and costing $40 billion annually. For acute low back pain, the short answer is to leave patients alone and for chronic pain, recommend back classes and functional rehabilitation. Red flags to evaluate for include cancer, infection, or neurological deficits. The goal is to distinguish the 95% with simple back pain from the 5% with a serious underlying problem. Conservative treatment including education, exercise, and over-the-counter medications is usually sufficient. Opioids are not recommended for chronic back pain due to lack of evidence of long-term benefit and risk of harm.
Atypical hus
This document summarizes a presentation on atypical hemolytic uremic syndrome (aHUS). The key points are:
1) Atypical HUS is caused by dysregulation of the alternative complement pathway leading to thrombotic microangiopathy. There is often an underlying genetic predisposition that is triggered by stressors like pregnancy.
2) Treatment with plasma therapy and transplantation previously had limited success due to recurrent disease.
3) The monoclonal antibody eculizumab, a C5 inhibitor, is highly effective at treating and preventing recurrence of aHUS. However, the high cost of the medication presents barriers to treatment.
Preop pulmonary evaluation 4 16-15
Mr. Lung is a 78-year-old man scheduled for a 4-hour L3-5 laminectomy and fusion who has severe COPD, diabetes, hypertension, and a 40 pack-year smoking history. He takes medications for his COPD and other conditions and is functionally independent but dyspneic with exertion. Preoperative evaluation shows he is at increased risk for postoperative pulmonary complications according to several risk prediction models. Recommendations are made for postoperative lung expansion techniques and monitoring to help mitigate his risks.
Bowen predm cme.4.9.15
Based on the evidence presented in the document, the appropriate recommendation for Mrs. K would be a lifestyle intervention with a goal of 7% weight loss (Option B). The DPP trial demonstrated that lifestyle intervention, aimed at 7% weight loss through diet and exercise, reduced the risk of developing diabetes by 58% over 3 years compared to placebo. This lifestyle intervention was more effective than metformin alone in preventing diabetes.
Bowen predm cme.4.9.15
1. The Diabetes Prevention Program (DPP) found that an intensive lifestyle intervention aimed at 7% weight loss was more effective than metformin or placebo at preventing diabetes in patients with prediabetes over 3 years, with a 58% reduction in relative risk.
2. For Mrs. K, an intensive lifestyle intervention targeting at least 7% weight loss would be the recommended first-line evidence-based approach based on the DPP findings.
3. After 1 year of lifestyle changes, Mrs. K had achieved 6% weight loss and normal fasting glucose and A1C levels, indicating response to treatment. However, 12 months later with 10 pounds regained, her glucose levels have
Cap2015
Community-acquired pneumonia (CAP) is a leading cause of death and hospitalization in the United States. Guidelines recommend using severity of illness scores like CURB-65 to determine appropriate site of care and empiric antibiotic therapy including β-lactams with macrolides or fluoroquinolones. Studies show guideline-concordant therapy improves outcomes. Procalcitonin levels may help determine duration of antibiotics, with lower levels associated with shorter treatment. Overall, clinicians should aim for 5-7 days of effective antibiotics guided by clinical and procalcitonin findings to optimize CAP treatment.
Resident update talk
This document summarizes information on altitude physiology and acute illnesses that can occur at high altitude. It discusses how oxygen levels decrease with increasing altitude, leading to tissue hypoxia. It describes the body's acclimatization process through various pulmonary, cardiovascular, cerebrovascular, and hematologic adaptations. The most common high altitude illnesses are acute mountain sickness, high altitude cerebral edema, and high altitude pulmonary edema. The document provides details on risk factors, symptoms, treatments, and prevention strategies for each of these illnesses. It emphasizes the importance of gradual ascent and allowing time for acclimatization to reduce risks.
Complications of cirrhosis review
This document discusses complications that can arise in patients with cirrhosis, including portal hypertension, ascites, hepatic encephalopathy, and hepatorenal syndrome. It provides details on the pathophysiology, clinical presentation, diagnosis, and treatment of these complications. Specifically, it focuses on portal hypertension and the development of varices, describing the risks of variceal bleeding and approaches to prevention and management. It also covers ascites extensively, explaining how and why it develops in cirrhosis and its treatment with diuretics and sodium restriction.
Bayat update talk
This document provides an overview of various food intoxications, covering bacteria such as Staphylococcus aureus, Bacillus cereus, Clostridium perfringens, and toxins including ciguatera, scombroid, tetrodotoxin, and domoic acid from contaminated shellfish. It describes the organisms and toxins involved, foods commonly associated with poisoning, symptoms, mechanisms of toxicity, and treatments for each type of food intoxication.
Peptic ulcer may 2015
This document summarizes key information about peptic ulcer disease and Helicobacter pylori (H. pylori). It discusses how H. pylori eradication benefits active gastric ulcer, past duodenal ulcer, and gastric MALT lymphoma. Proton pump inhibitors, sucralfate, and misoprostol are effective in decreasing NSAID-induced ulcers. H. pylori infection is associated with gastric adenocarcinoma through a sequence of events. Triple therapy is the preferred first line treatment for H. pylori, while quadruple therapy is used for retreatment. Risk of NSAID-induced ulcers increases with corticosteroid use, anticoagulant use,
March 192015talkforresidents final03232015 (1)
This document provides an update on viral hepatitis and discusses two case studies. It begins by describing a 71-year-old male presenting with jaundice who is diagnosed with acute hepatitis A infection based on a reactive HAV IgM test. It then reviews hepatitis A virus and the diagnosis and management of acute hepatitis A. The second case discusses a 26-year-old male diagnosed with chronic hepatitis B infection based on positive HBsAg, anti-HBc IgM, and HBV DNA tests. The document concludes by discussing chronic hepatitis B infection and approved treatments.
Final ipf journal club presentation
This summary reviews a journal club discussion on two phase 3 clinical trials evaluating the efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF). The trials found that nintedanib significantly reduced the rate of decline in forced vital capacity (FVC) over 52 weeks compared to placebo. There was no consistent effect on time to first acute exacerbation or change in symptoms. Common side effects included diarrhea. While the study design was valid, questions remain regarding the clinical significance of the outcomes and relevance of factors like smoking status.
Res update final
This document discusses the increasing use of therapeutic monoclonal antibodies in internal medicine. It provides examples of monoclonal antibodies used in various specialties like hematology/oncology, rheumatology, gastroenterology, and cardiology. The document outlines the historical development of monoclonal antibody technology from the 1890s to modern advances in recombinant DNA and transgenic mice that have allowed for humanized monoclonal antibodies. It notes both the benefits monoclonal antibodies have provided but also the issues of diminishing response, high costs, and sometimes unanticipated safety risks. The document concludes by predicting more monoclonal antibody approvals and emphasizes the need for rigorous evaluation of safety, efficacy and cost-effectiveness as with other medical therapies.
Resident update talk jtw online
This document summarizes various approaches for managing type 1 diabetes, including the bionic pancreas, islet transplantation, and stem cell therapy. It notes that the bionic pancreas can help improve glucose control but has limitations like being invasive and not physiological. Islet transplantation via the Edmonton protocol can cure diabetes, but challenges remain in expanding the donor supply and improving techniques. Stem cell therapy shows promise if stem cells can be encapsulated to both differentiate into insulin-producing cells and avoid immune rejection. Overall, a cure exists on the horizon, but further progress is still needed to overcome immune issues and increase donor availability.
Hfpef
HFPEF is defined as clinical signs of congestive heart failure with a preserved left ventricular ejection fraction over 50%. It accounts for about half of all heart failure cases and is associated with significant mortality. The pathophysiology involves abnormal ventricular stiffness from an upward and leftward shift in the end diastolic pressure-volume relationship. This results in poor exercise tolerance and fatigue. While the exact causes are unclear, comorbidities like hypertension, diabetes and obesity likely play a key role. No treatments shown to improve outcomes for heart failure with reduced ejection fraction have been effective for HFPEF.
IBD
This document discusses the diagnosis and management of ulcerative colitis and Crohn's disease. It defines the diseases, describes their classification systems and severity indices. It covers epidemiology, pathogenesis, diagnostic testing and differential diagnoses. Treatment strategies are outlined for induction and maintenance of remission for mild to severe ulcerative colitis. Management of Crohn's disease is discussed including medications such as aminosalicylates, corticosteroids, immunomodulators, biologics and their monitoring. Surgical options are also summarized.
Noon conference Pancreatic disorders
This document discusses pancreatic function and pathophysiology of pancreatitis. It covers the exocrine and endocrine functions of the pancreas. For acute pancreatitis, it details etiologies including gallstones, alcohol, hypertriglyceridemia, drugs, infections and others. It discusses clinical presentation, severity scoring, management including nutrition and imaging. For chronic pancreatitis, it covers presentation, complications and treatments.
Resident updatetalk
This document discusses cardiac amyloidosis, a rare disorder where abnormal proteins deposit in the heart muscle, causing restrictive cardiomyopathy. It begins by describing the patient case of a man presenting with heart failure symptoms and an echocardiogram showing thickened heart walls. The document then provides background on amyloidosis, including definitions, types, pathogenesis, typical symptoms, diagnostic methods like biopsy, and treatments like chemotherapy, stem cell transplant, and newer therapies.
Resident updatetalk
This document discusses cardiac amyloidosis, a rare disease where abnormal proteins deposit in the heart muscle, causing restrictive cardiomyopathy. It begins by describing the case of a 53-year-old man presenting with chest discomfort and edema. The document then provides background on amyloidosis, including its historical context and pathophysiology. It describes the typical presentation of cardiac amyloidosis and diagnostic methods. The document concludes by reviewing current treatments and their outcomes, such as stem cell transplantation which can achieve long-term remission in some patients.
More from katejohnpunag (20)
Recently uploaded
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
Recently uploaded (20)
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology